ESR1 and breast carcinoma: These data indicate that re−expression of ER−α by pentadecanoic acid alone or in combination contributes to restoration of tamoxifen sensitivity and reversal of tamoxifen resistance in ER−under−expressing MCF−7/SC breast cancer cells.